Related Experiment Video
Updated: Jul 26, 2026

09:00
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges
Anton W Langerak1, Monika Brüggemann2, Frédéric Davi3
1Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center, 3015 CN Rotterdam, the Netherlands; a.langerak@erasmusmc.nl.
Journal of Immunology (Baltimore, Md. : 1950)
|April 19, 2017
Summary
Next-generation sequencing (NGS) offers deeper insights into immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements, overcoming limitations of older methods. The EuroClonality-NGS Consortium standardizes this workflow for improved immunogenetic analysis in research and clinical settings.
Area of Science:
- Immunogenetics
- Molecular Biology
- Bioinformatics
Background:
- Conventional analysis of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements has inherent limitations in resolution, coverage, and bias.
- High-throughput, next-generation sequencing (NGS) technologies present an opportunity for more comprehensive IG/TR gene rearrangement analysis.
Purpose of the Study:
- To bridge the gap between low-throughput and high-throughput IG/TR analysis by developing, standardizing, and validating NGS assays.
- To address key applications including clonality assessment, minimal residual disease detection, and repertoire analysis.
- To critically evaluate the pitfalls and challenges associated with IG/TR NGS methodology.
Main Methods:
- Development and standardization of a comprehensive IG/TR NGS workflow.
- Inclusion of preanalytical (sample preparation, target selection), analytical (amplification, sequencing), and postanalytical (immunoinformatics) phases.
- Validation of the standardized NGS methodology for immunogenetic applications.
Main Results:
- Establishment of a standardized workflow for IG/TR gene rearrangement analysis using NGS.
- Demonstration of improved resolution, coverage, and reduced bias compared to conventional methods.
- Identification of critical challenges and pitfalls in IG/TR NGS implementation.
Conclusions:
- NGS technology significantly enhances IG/TR immunogenetic analysis, impacting clonality assessment, MRD detection, and repertoire studies.
- Standardization and validation are crucial for reliable IG/TR NGS assays.
- Addressing methodological challenges is key to fully realizing the potential of IG/TR NGS in hemato-oncology and immunology.

